Hot Off The Press
November 7, 2012 - At the 68th Annual Meeting of the American Society for Reproductive Medicine last month, fertility experts issued a new report on egg freezing, lifting its "experimental" label in certain cases. The report stated that in young patients egg freezing techniques have been shown to produce pregnancy rates, leading to the birth of healthy babies, comparable to IVF cycles using fresh eggs.
Jean Enersen, of www.King5.com, a Seattle news site, posted this news article and video about a 24 year old woman who, when diagnosed with brain cancer, chose to preserve her fertility with oocyte cryopreservation (egg freezing). The story also features Leah Kroon, oncology nurse in Seattle Children's Hospital's Adolescent and Young Adult (AYA) Cancer Program, a great advocate in the fight for young patients' options for fertility preservation. Thank you to these two ladies for your fight for fertility preservation, and to Seattle Children's Hospital staff for discussing fertility preservation with all of its patients.
October 19, 2012 - ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), has released Version 2.0 of its free Fertility Preservation App for Apple devices.
October 17, 2012 - ReproTech, Ltd. president, Russ Bierbaum, was invited to speak to infertility and OB/GYN medical professionals at Nursing Symposium.
September 29, 2012 - Holmes Regional Medical Center's Auditorium in Melbourne, FL was the setting for a presentation entitled Fertility Preservation for the Oncology Patient. This program strives to promote education and extend access to fertility preservation services.
September 24, 2012 - ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), was invited to speak on the topic of fertility preservation for oncology patients.
Just to set things straight...
A recent article in the Washington Post notes some inaccurate statistics regarding donated embryos, as it confuses embryo donation with egg (oocyte) donation. Just to set things straight, the numbers quoted in the 2003 and 2010 statements, according to the Society for Assisted Reproductive Technology (SART), are for Donor Oocytes, not embryos. It is confusing, as the SART website labels the stats "Fresh Embryos" and "Thawed Embryos". These labels actually refer to the embryos created from Donor Oocytes. The statements would be accurate if the words "embryos" were replaced with "oocytes".
In honor of National Ovarian Cancer Month and Gynecologic Cancer Month, both taking place in September, Walgreens and Ferring Pharmaceuticals Inc. today announced a collaboration to provide free access to certain fertility medications and educational resources as part of Ferring's h.e.a.r.t. BEAT program. The program is a patient assistance initiative funded by Ferring and provided as a public service to eligible women of reproductive age who have received a new cancer diagnosis and wish to undergo fertility preservation prior to the start of their cancer treatment.
There are no financial requirements or applications to complete. Patients must be:
- U.S. citizen or permanent resident
- Diagnosis of cancer
- Cancer treatment has not been initiated
- No recent chemotherapy treatment within prior six months
- Oncologist and Reproductive Endocrinologist determine that Fertility Preservation treatment is medically appropriate
The fertility medications, manufactured by Ferring Pharmaceuticals Inc., included in the h.e.a.r.t. BEAT progam are BRAVELLE®, MENOPUR® and NOVAREL®. Physicians may call Walgreens Specialty Pharmacy at 888-347-3415 with a verbal prescription and the medication will be shipped via UPS to either the physician's office or the patient. No completion of forms is required.
September 10, 2012 - This article on birth through cryopreservation of sperm stored for over 40 years was recently posted on ASRM's website. Although the client's situation is unusual, the article proves how effective cryopreservation techniques and equipment are and have become, even after 40 years of storage. We realize most patients will not keep specimens in cryostorage for this length of time, but the point is that we know it is possible to confidently do so. Men who are considering sperm banking now have even more proof that their cryospreserved specimens will be viable when they are ready to have a family.
The technical article related to this story, "Live births from frozen human semen stored for 40 years" was published in the April online issue of the Journal of Assisted Reproduction and Genetics. The final publication is available at link.springer.com.
September 7, 2012 - ReproTech, Ltd., a cryobank specializing in storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), reached an agreement with Coastal Fertility Specialists, adding the facility to the more than 100 facilities included in ReproTech's Fertility Preservation Network.
September 5, 2012 - ReproTech, Ltd., a cryobank specializing in storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), reached an agreement with IVF New Jersey, adding the facility to the more than 100 facilities included in ReproTech's Fertility Preservation Network.